Table 3. Univariate analysis of predictors of mortality in a treatment cohort of South African XDR-TB patients.
Deceased Number/total (%) |
Survivors Number/total (%) |
P value | Univariate Hazard Ratio (95% CI) |
||
---|---|---|---|---|---|
Sex | Female | 13/25 (52) | 21/35 (60) | 0.36 | 0.69 (0.31-1.52) |
Age (years) | 50+ | 2/25 (8) | 4/35 (11) | 0.66 | 0.67 (0.11-4.00) |
Previous TB Treatment | Yes | 17/25 (68) | 26/35 (74) | 0.69 | 0.78 (0.23-2.67) |
Previous MDR-TB Diagnosis | Yes | 8/25 (32) | 14/35 (40) | 0.59 | 0.89 (0.34-2.32) |
HIV Infected | Yes | 18/23 (78) | 25/32 (78) | 0.90 | 0.96 (0.52-1.78) |
CD4 count (cells/mm3) | Less than 200 | 7/9 (78) | 9/20 (45) | 0.16 | 3.07 (0.64-14.79) |
On HAART | Yes | 8/25 (32) | 13/35 (37) | 0.75 | 0.87 (0.38-2.02) |
Severe AEs* | Yes | 6/18 (33) | 11/32 (34) | 0.94 | 0.94 (0.35-2.51) |
AEs- Adverse Events